Founded in 2017, Fujian ComHony Biotechnology Co., Ltd. is a high-end biomedical enterprise integrating R&D, production and sales. With a total investment of 600 million RMB, the company occupies 83 mu (about 55,333 square meters) of production land and a total construction area of 35,707.89 square meters.

The company is equipped with workshops for biological culture, drug purification, drug synthesis and drug refinement, as well as supporting warehouses and an R&D engineering center. Its core equipment and processes are internationally advanced, with a high degree of automated production. The production environment is managed in strict accordance with GMP requirements, supported by advanced testing instruments and experienced professional personnel.

The company’s main products cover more than 20 varieties, including:

· Anti-infective products (9 products in production, such as Mupirocin)

· Veterinary products (such as Kanamycin Monosulfate)

· New functional food products (such as Pyrroloquinoline Quinone, PQQ)

These products meet a wide range of health demands.

The company holds 10 invention patents and 36 authorized utility model patents. It has been awarded the certificate of “High-Tech Enterprise” and selected as a “Specialized, Sophisticated, Unique and New” Small and Medium-sized Enterprise in Fujian Province.

As a biomedical API production base, the company has passed multiple certifications including ISO9001 and domestic GMP. Many products are registered with EU EDQM, FDA and NMPA, with main products holding EU CEP certificates.

In the future, the company will expand its product lines into anti-tumor, anti-infective and functional medical foods, practice green and sustainable development, and build a world-class brand in the global biotechnology industry.